MYXREDLIN
NDC 0338-0126, insulin human, injection, solution, from Baxter Healthcare Corporation.
- Product NDC
- 0338-0126
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA208157
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0126 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN HUMAN1 [iU]/mL
Pharmacologic classes
Insulin [CS]; Insulin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0338-0126-12 | 00338012612 | 12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/afca6e80-a802-49fb-a978-5fe28a173001
Use it
Look up 0338-0126 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0126 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0338-0126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.